U.S., Jan. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07338968) titled 'A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma' on Nov. 21, 2025.
Brief Summary: AU-011-403 is a multicenter long-term follow-up safety and efficacy study of subjects with early CM who previously participated in the AU-011-301 Phase 3 trial. There are no required interventions or use of AU-011 (bel-sar) in this long-term follow-up study
Study Start Date: Feb. 01
Study Type: OBSERVATIONAL
Condition:
Choroidal Melanoma
Indeterminate Lesions
Intervention:
OTHER: Observational
The intention is to collect data for an additional ~5 years (Post AU-011-301 participation)
Recru...